Federal contract award
75F40122C00161
STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOME.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $9.7M |
| Current contract value | $9.7M |
| Potential contract value / ceiling | $9.7M |
| Start date | Sep 27, 2022 |
| Current end date | Sep 17, 2025 |
| Potential end date | Sep 17, 2025 |
| Latest award activity | Sep 19, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 19, 2025 | P00004 | $0 | STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOME. |
| Sep 17, 2025 | P00003 | $0 | STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOME. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.